Similar companies
| Company | Revenue | |
|---|---|---|
 |
ProgressivePGR |
22.5B 2.3% |
 |
Chubb LimitedCB |
-22.8B 253% |
Income Statement (NONE)
| Q3 '25 | QoQ | |
|---|---|---|
| Revenue | 50.7B | 1.9% |
| Gross Profit | 7.19B | 85.6% |
| Cost of Revenue | 43.5B | 3.6% |
| Operating expense | 5.43B | 88.6% |
| Net Income | 1.19B | 31.8% |
| EBITDA | 1.76B | 41.7% |
Balance Sheet (NONE)
| Q3 '25 | QoQ | |
|---|---|---|
| Total Assets | 123B | 0.7% |
| Total Liabilities | 78.7B | 0.7% |
| Total Equity | 44B | 0.5% |
| Shares Outstanding | 226M | 0% |
Cash Flow (NONE)
| Q3 '25 | QoQ | |
|---|---|---|
| Cash from operations | 1.14B | 44.7% |
| Cash from investing | -1.22B | 78.2% |
| Cash from financing | 243M | 178.9% |
EPS
Financial Highlights for Elevance Health in Q3 '25
Elevance Health reported a revenue of 50.7B, which is a 1.9% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 7.19B, marking a -85.6% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 43.5B, a 3.6% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 5.43B, showing a -88.6% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was 1.19B, showing a -31.8% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was 1.76B, showing a -41.7% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
Elevance Health faced some challenges this quarter with a decline in one or more of the key metrics: revenue, gross profit, or net income. An increase in the cost of revenue, higher than the revenue growth, suggests potential margin pressures. A decline in EBITDA signals potential operational challenges or increased costs.
